Forian Inc. (NASDAQ:FORA – Get Free Report) shot up 1% during trading on Tuesday . The stock traded as high as $2.06 and last traded at $2.05. 4,898 shares were traded during trading, a decline of 56% from the average session volume of 11,125 shares. The stock had previously closed at $2.03.
Wall Street Analysts Forecast Growth
Separately, Roth Mkm reaffirmed a “buy” rating and set a $5.00 price target on shares of Forian in a research note on Thursday, November 14th.
Get Our Latest Report on Forian
Forian Price Performance
Institutional Trading of Forian
An institutional investor recently bought a new position in Forian stock. Caprock Group LLC bought a new stake in Forian Inc. (NASDAQ:FORA – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 86,784 shares of the company’s stock, valued at approximately $230,000. Caprock Group LLC owned approximately 0.28% of Forian as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 19.25% of the company’s stock.
About Forian
Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.
Read More
- Five stocks we like better than Forian
- What is the S&P/TSX Index?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Most Volatile Stocks, What Investors Need to Know
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Forian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Forian and related companies with MarketBeat.com's FREE daily email newsletter.